KG
BMY icon

Kilter Group’s Bristol-Myers Squibb BMY Stock Holding History

Kilter Group’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$33.5K Buy
552
+101
+22% +$5.89K 0.01% 163
2025
Q4 		$24.3K Buy
451
+69
+18% +$3.32K 0.01% 186
2025
Q3 		$17.2K Buy
382
+61
+19% +$2.85K 0.01% 211
2025
Q2 		$14.9K Buy
+321
New +$15.8K 0.01% 211

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Kilter Group's BMY Position: Q1 2026 in Review

Kilter Group increased its Bristol-Myers Squibb (BMY) stake by 22% in Q1 2026, buying an estimated $5.89K and bringing the position to 552 shares worth $33.5K. The position accounts for 0.01% of the portfolio, ranked #163.

Kilter Group first reported a position in BMY in Q2 2025 and has held it in 4 quarters since. 2,518 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Kilter Group held 552 shares of Bristol-Myers Squibb worth $33.5K as of Q1 2026.
  • Kilter Group bought 101 Bristol-Myers Squibb shares in Q1 2026, an estimated $5.89K.
  • Bristol-Myers Squibb made up 0.01% of Kilter Group's portfolio in Q1 2026, its #163 holding.
  • Kilter Group first reported a position in Bristol-Myers Squibb in Q2 2025 and has held it in 4 quarters since.
  • 2,518 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Kilter Group's 13F filing for Q1 2026, filed 14 May 2026.